OTC Markets OTCQB - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

Compare
20.24 +0.24 (+1.20%)
As of 9:51 AM EDT. Market Open.
Loading Chart for ZIVO
DELL
  • Previous Close 20.00
  • Open 20.24
  • Bid 19.60 x 43500
  • Ask 20.40 x 36900
  • Day's Range 20.24 - 20.24
  • 52 Week Range 0.48 - 20.50
  • Volume 22
  • Avg. Volume 1,306
  • Market Cap (intraday) 70.038M
  • Beta (5Y Monthly) 0.27
  • PE Ratio (TTM) --
  • EPS (TTM) -5.33
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.00

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

www.zivobioscience.com

8

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZIVO

View More

Performance Overview: ZIVO

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZIVO
1,586.67%
S&P 500
22.10%

1-Year Return

ZIVO
349.78%
S&P 500
34.57%

3-Year Return

ZIVO
18.71%
S&P 500
30.25%

5-Year Return

ZIVO
3,648.15%
S&P 500
94.41%

Compare To: ZIVO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZIVO

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    69.21M

  • Enterprise Value

    69.78M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    789.90

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.18k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,261.20%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    59.32k

  • Net Income Avi to Common (ttm)

    -13.25M

  • Diluted EPS (ttm)

    -5.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.47k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -18.14k

Research Analysis: ZIVO

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 35.72k
Earnings -1.28M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

12.00 Low
12.00 Average
20.24 Current
12.00
 

Company Insights: ZIVO

People Also Watch